We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

In re: Alfuzosin Hydrochloride Patent Litigation

  1. January 14, 2011

    Sanofi Beats Back Apotex Generic In Uroxatral MDL

    A federal judge overseeing the multidistrict litigation arising from Sanofi-Aventis SA’s prostate drug Uroxatral has held that the patent covering the treatment was valid and infringed by Apotex Inc.’s proposed generic copycat.

  2. August 19, 2010

    Aurobindo, Torrent Infringe Sanofi's Uroxatral IP: Judge

    A federal judge has ruled that Sanofi-Aventis’ patent covering prostate treatment Uroxatral is valid and infringed by proposed generic versions from Aurobindo Pharma Ltd. and Torrent Pharma Inc.

  3. May 17, 2010

    Mylan Generic Infringes Sanofi's Uroxatral Patent: Judge

    A federal judge has given Sanofi-Aventis SA a boost in its multidistrict litigation over competitors' attempts to market a generic version of prostate treatment Uroxatral, ruling at trial that the drug proposed by Mylan Pharmaceutical Inc. would in fact infringe Sanofi’s patent.

  4. May 20, 2009

    Sanofi Uroxatral Claim Construction Gets Judge's Nod

    A federal judge has handed down a claim construction order for one of the patents in Sanofi-Aventis’ multidistrict litigation alleging Mylan Pharmaceuticals Inc. and other generic-drug manufacturers have infringed its technology covering its prostate treatment, Uroxatral.

  5. June 13, 2008

    Sanofi Asserts 2nd Uroxatral Patent Against Sun

    Sanofi-Aventis has hit Sun Pharmaceutical Industries Ltd. with another patent infringement suit over the drug Uroxatral, alleging that the generics maker infringed another of its patents for the prostate treatment.